NCT00574392View on ClinicalTrials.gov

Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Basal Cell CarcinomaMelanomaNon-Malignant Skin DisordersSquamous Cell Carcinoma
Interventions
DEVICE

Multiwavelength and coherence confocal reflectance microscopy (Vivascope 1500m multiwavelength)

Patients will be imaged with the Vivascope 1500m multiwavelength coherence microscope during a single patient visit. The lesion will be photographed with high resolution photography and surface epiluminescence microscopy. The clinically uninvolved site will be imaged in the same manner.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Rochester

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00574392 - Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo | Biotech Hunter | Biotech Hunter